The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

Adler M, Gulbis B, Moreno C, Evrard S, Verset G …

MeSH — NLM indexing Hepacivirus / genetics Hepacivirus / isolation & purification Hepatitis C / blood Hepatitis C / diagnosis Hepatitis C / pathology Humans Liver Cirrhosis / pathology Predictive Value of Tests RNA, Viral / blood Reproducibility of Results Viral Load

Sur le même sujet

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Biomedicines · 2025

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

World J Hepatol · 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Cardiovasc Diabetol · 2025

Noninvasive Assessment of Liver Fibrosis.

N Engl J Med · 2025

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Diabetes Care · 2025

Toward non-invasive assessment strategies in autoimmune hepatitis.

World J Hepatol · 2025